Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Medtronic
Covington
US Army
US Department of Justice
Novartis
Healthtrust
Cipla
Fuji

Generated: December 12, 2017

DrugPatentWatch Database Preview

Iohexol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for iohexol and what is the scope of iohexol freedom to operate?

Iohexol
is the generic ingredient in eight branded drugs marketed by Interpharma Praha As and Ge Healthcare, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are three drug master file entries for iohexol. Three suppliers are listed for this compound.

Pharmacology for iohexol

Medical Subject Heading (MeSH) Categories for iohexol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Ge HealthcareOMNIPAQUE 180iohexolSOLUTION;INJECTION, ORAL, RECTAL018956-001Dec 26, 1985RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 140iohexolINJECTABLE;INJECTION018956-005Nov 30, 1988RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 300iohexolSOLUTION;INJECTION, ORAL, RECTAL018956-003Dec 26, 1985RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 210iohexolINJECTABLE;INJECTION018956-006Jun 30, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Interpharma Praha AsORALTAGiohexolFOR SOLUTION;ORAL205383-001Mar 26, 2015RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 350iohexolSOLUTION;INJECTION, ORAL018956-004Dec 26, 1985RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 240iohexolSOLUTION;INJECTION, ORAL, RECTAL020608-001Oct 24, 1995RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 240iohexolSOLUTION;INJECTION, ORAL, RECTAL018956-002Dec 26, 1985RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 70iohexolSOLUTION;URETHRAL018956-007Jun 1, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 350iohexolSOLUTION;INJECTION, ORAL020608-003Oct 24, 1995RXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: iohexol

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Ge HealthcareOMNIPAQUE 70iohexolSOLUTION;URETHRAL018956-007Jun 1, 1994► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 180iohexolSOLUTION;INJECTION, ORAL, RECTAL018956-001Dec 26, 1985► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 300iohexolSOLUTION;INJECTION, ORAL, RECTAL018956-003Dec 26, 1985► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 240iohexolSOLUTION;INJECTION, ORAL, RECTAL018956-002Dec 26, 1985► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 140iohexolINJECTABLE;INJECTION018956-005Nov 30, 1988► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 180iohexolSOLUTION;INJECTION, ORAL, RECTAL018956-001Dec 26, 1985► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 300iohexolSOLUTION;INJECTION, ORAL, RECTAL018956-003Dec 26, 1985► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 180iohexolSOLUTION;INJECTION, ORAL, RECTAL018956-001Dec 26, 1985► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 350iohexolSOLUTION;INJECTION, ORAL018956-004Dec 26, 1985► Subscribe► Subscribe
Ge HealthcareOMNIPAQUE 350iohexolSOLUTION;INJECTION, ORAL018956-004Dec 26, 1985► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Moodys
Teva
Fish and Richardson
Queensland Health
Mallinckrodt
Fuji
Argus Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot